A Patient-Centered Approach to Psychedelic-Assisted Therapy - Dr. Manish Agrawal, Co-Founder and CEO of Sunstone Therapies

“With psychedelics right now, there's a lot of hype around the compound, which is somewhat important, but Sunstone Therapies is really founded on the belief that the delivery is more important than the drug,” says Dr. Manish Agrawal, the company’s co-founder and CEO. As interest in the use of psychedelics for mental health treatment grows and various compounds continue to move down the path of FDA approval, Agrawal wants to be sure the medical system is prepared to provide the safest and most effective experience for patients.  In fact, his company is conducting clinical trials to help define the standards for optimal patient care. Serious thought is given to everything from lighting to how patients are greeted, and of course there is great emphasis placed on training therapists properly and supporting them as they do what can be emotionally taxing work. “When people come through Sunstone, we want them to feel loved and held -- because they're dealing with very difficult issues -- but also the rigor and the discipline of a very thorough process that is very safe.” Listen to this super thoughtful conversation with host Shiv Gaglani as Agrawal discusses a new model of mental health care, psychedelic-assisted group therapy, and the transformative results he’s seen in patients. “In the right context with the right amount of support and understanding, psychedelics can help people resolve difficult emotions.”Mentioned in this episode: https://www.sunstonetherapies.com/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast